Literature DB >> 11781281

Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer.

Andrei V Ougolkov1, Kaname Yamashita, Masayoshi Mai, Toshinari Minamoto.   

Abstract

BACKGROUND & AIMS: Recent in vitro studies showed that beta-catenin translocated into the tumor cell nucleus functions as an oncogene by transactivating oncogenes, including MMP-7. We conducted a large-scale analysis of beta-catenin and MMP-7 expression in human colon cancer to determine the potential clinical importance of these molecules.
METHODS: In 202 colon cancer patients with known postoperative outcomes, we determined the expression of beta-catenin and MMP-7 in the tumors immunohistochemically and correlated the findings with the patients' clinicopathological characteristics and survival.
RESULTS: We found 2 distinct patterns of beta-catenin nuclear accumulation (NA) in the colon cancers: diffuse NA (NAd) in 89 cases (44%) and selective NA at the invasion front (NAinv) in 18 cases (9%). The presence of the NAinv pattern was significantly correlated with advanced Dukes' stage (P = 0.0187) and tumor recurrence (P = 0.0005) as well as with MMP-7 expression in the tumor invasion front (P = 0.0025), resulting in extremely unfavorable clinical outcomes. A multivariate analysis determined that the NAinv expression pattern and Dukes' C stage were independent prognostic factors.
CONCLUSIONS: Oncogenic activation of beta-catenin in the tumor invasion front, as represented by its NAinv pattern of expression, may be an independent and reliable indicator of membership in a subset of colon cancer patients who are highly susceptible to tumor recurrence and have a less favorable survival rate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11781281     DOI: 10.1053/gast.2002.30306

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  33 in total

1.  A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.

Authors:  Giuseppe Pelosi; Aldo Scarpa; Giulia Veronesi; Lorenzo Spaggiari; Barbara Del Curto; Patrick S Moore; Patrick Maisonneuve; Angelica Sonzogni; Michele Masullo; Giuseppe Viale
Journal:  Virchows Arch       Date:  2005-09-13       Impact factor: 4.064

2.  Nuclear translocation of β-catenin correlates with CD44 upregulation in Helicobacter pylori-infected gastric carcinoma.

Authors:  Gopal Udhayakumar; Venkatraman Jayanthi; Niranjali Devaraj; Halagowder Devaraj
Journal:  Mol Cell Biochem       Date:  2011-06-16       Impact factor: 3.396

3.  Frequent loss of membranous E-cadherin in gastric cancers: A cross-talk with Wnt in determining the fate of beta-catenin.

Authors:  Xiao-Xin Cheng; Zi-Chuang Wang; Xiao-Yan Chen; Yuan Sun; Qing-You Kong; Jia Liu; Xue Gao; Hong-Wei Guan; Hong Li
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers.

Authors:  S Kurokawa; Y Arimura; H Yamamoto; Y Adachi; T Endo; T Sato; T Suga; M Hosokawa; Y Shinomura; K Imai
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

Review 5.  The Wnt signaling pathway and its role in tumor development.

Authors:  B Lustig; J Behrens
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-18       Impact factor: 4.553

6.  Down-regulation of matrix metalloproteinase-7 inhibits metastasis of human anaplastic thyroid cancer cell line.

Authors:  Szu-Tah Chen; Dah-Wel Liu; Jen-Der Lin; Fang-Wu Chen; Yu-Yao Huang; Brend Ray-Sea Hsu
Journal:  Clin Exp Metastasis       Date:  2011-11-01       Impact factor: 5.150

7.  Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor.

Authors:  Celine J Guigon; Li Zhao; Changxue Lu; Mark C Willingham; Sheue-Yann Cheng
Journal:  Mol Cell Biol       Date:  2008-05-12       Impact factor: 4.272

Review 8.  Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?

Authors:  G-T Ho; F M Moodie; J Satsangi
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

9.  Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells.

Authors:  Heui-Young Ryu; Jiseon Lee; Sanghwa Yang; Haein Park; Sojoong Choi; Kyeong-Cheon Jung; Seung-Taek Lee; Je-Kyung Seong; Inn-Oc Han; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

10.  MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells.

Authors:  Yu-Jing Fang; Zhi-Zhong Pan; Li-Ren Li; Zhen-Hai Lu; Li-Yi Zhang; De-Sen Wan
Journal:  J Exp Clin Cancer Res       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.